- Research works
- 28 ▲ 164% vs 2013–17
- Citations
- 420 15.3 per fractional work
- Top-10% rate
- 30.3% record average 16.5%
- Open access
- 55% world 28%
Not ranked overall: ADMED (Switzerland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 7.9×. Every wedge is a field page.
Which keywords describe research at ADMED (Switzerland)?
By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Diagnosis, Bacteremia, Ethical Considerations, Immunosuppression, Transplantation, Pathogenesis and Face.
- Clusterin
- Vaccine Development
- Metastasis
- Chemotherapy
- Treatment
- Face
- Transplantation
- Pathogenesis
- Ethical Considerations
- Diagnosis
- Epidemiology
- Bacteremia
- Immunosuppression
- Public Health
- Cancer
- Uterus
- Antibiotic Resistance
- Genetic Diversity
- Apoptosis
- Chaperone
- Pathogen Transmission
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 21 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 21 words, with their numbers
- Epidemiology7▲ 6.2×33 topics
- Diagnosis2▲ 7.7×10 topics
- Bacteremia2▲ 89×3 topics
- Ethical Considerations2▲ 21×4 topics
- Immunosuppression2▲ 56×2 topics
- Pathogenesis2▲ 11×10 topics
- Public Health2▲ 4.4×6 topics
- Transplantation2▲ 54×2 topics
- Cancer2▲ 4.2×5 topics
- Face2▲ 448×1 topic
- Uterus2▲ 448×1 topic
- Treatment1▲ 4.0×7 topics
- Antibiotic Resistance1▲ 11×7 topics
- Chemotherapy1▲ 6.0×6 topics
- Genetic Diversity1▲ 8.6×3 topics
- Metastasis1▲ 13×3 topics
- Apoptosis1▲ 9.9×2 topics
- Vaccine Development1▲ 13×5 topics
- Chaperone1▲ 189×1 topic
- Clusterin1▲ 844×1 topic
- Pathogen Transmission1▲ 58×2 topics
Which research topics does ADMED (Switzerland) publish most on?
By volume in 2022–2025: Organ and Tissue Transplantation Research, Bacterial Identification and Susceptibility Testing, Viral Infections and Vectors and Vector-borne infectious diseases.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Organ and Tissue Transplantation Research Transplantation 1 works
- 2 Bacterial Identification and Susceptibility Testing Clinical Biochemistry 1 works
- 3 Viral Infections and Vectors Infectious Diseases 0 works
- 4 Vector-borne infectious diseases Parasitology 0 works
- 5 Mosquito-borne diseases and control Public Health, Environmental and Occupational Health 0 works
- 6 Glaucoma and retinal disorders Ophthalmology 0 works
- 7 Ocular Diseases and Behçet’s Syndrome Ophthalmology 0 works
- 8 Corneal surgery and disorders Radiology, Nuclear Medicine and Imaging 0 works
- 9 Breast Lesions and Carcinomas Pathology and Forensic Medicine 0 works
- 10 COVID-19 Clinical Research Studies Infectious Diseases 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has ADMED (Switzerland)'s research output changed?
Output in 2018–2022 was 164% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Neuchâtel
- University of Neuchâtel
- Victoria School of Management
- Swiss Center for Electronics and Microtechnology (Switzerland)
- Observatoire Cantonal de Neuchâtel
- Hospital Neuchâtel
- Federal Statistical Office
- info fauna
- HES-SO Arc
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.